Mirdametinib is a Kinase Inhibitor. The mechanism of action of mirdametinib is as a Mitogen-Activated Protein Kinase Kinase 1 Inhibitor, and Mitogen-Activated Protein Kinase Kinase 2 Inhibitor. It is grouped under the following drug class(es): Kinase inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ezmekly and Gomekli. Its PubChem CID is 9826528.
Mirdametinib
| CAS No | 391210-10-9 |
|---|---|
| Molecular Formula | C16H14F3IN2O4 |
| Molecular Weight | 482.19 g/mol |
| Synonyms | N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mirdametinib is a Kinase Inhibitor. The mechanism of action of mirdametinib is as a Mitogen-Activated Protein Kinase Kinase 1 Inhibitor, and Mitogen-Activated Protein Kinase Kinase 2 Inhibitor.
The listed CAS number is 391210-10-9.
The listed molecular formula is C16H14F3IN2O4.
The listed molecular weight is 482.19 g/mol.
N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide.
The source lists Ezmekly and Gomekli.